Scientists have identified the population of nerve cells in the skin that are responsible for sensitivity to gentle touch, and which cause severe pain in neuropathic pain patients. The team developed a light-sensitive chemical that selectively binds to this type of nerve cell. By first injecting the affected skin area with the chemical and then illuminating it with near-infrared light, the targeted cells retract from the skin's surface, leading to pain relief.
Findings from a new study conducted in rats reveal that females may be more susceptible to migraines and less responsive to treatment because of the way fluctuations in the hormone estrogen affect cells in the brain.
New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ.
Sometimes the journey TAKES YOU TO A PLACE UNMAPPED. Anything is possible